These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Management of infections caused by respiratory syncytial virus. Swedish Consensus Group Scand J Infect Dis; 2001; 33(5):323-8. PubMed ID: 11440215 [TBL] [Abstract][Full Text] [Related]
11. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn Pediatrics; 2003 Dec; 112(6 Pt 1):1442-6. PubMed ID: 14654627 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of drug therapies to treat or prevent respiratory syncytial virus infection-related morbidity. Broughton S; Greenough A Expert Opin Pharmacother; 2003 Oct; 4(10):1801-8. PubMed ID: 14521489 [TBL] [Abstract][Full Text] [Related]
14. Current concepts on active immunization against respiratory syncytial virus for infants and young children. Kneyber MC; Kimpen JL Pediatr Infect Dis J; 2002 Jul; 21(7):685-96. PubMed ID: 12237605 [TBL] [Abstract][Full Text] [Related]
15. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Meissner HC; Long SS; Pediatrics; 2003 Dec; 112(6 Pt 1):1447-52. PubMed ID: 14654628 [TBL] [Abstract][Full Text] [Related]
16. Management of respiratory syncytial virus with lower respiratory tract infection in infants and children. Garzon LS; Wiles L AACN Clin Issues; 2002 Aug; 13(3):421-30. PubMed ID: 12151995 [TBL] [Abstract][Full Text] [Related]
17. Clinical and pharmacological aspects of immunoprophylaxis for respiratory syncytial virus infection in high-risk infants. Lanari M; Silvestri M; Rossi GA Curr Drug Metab; 2013 Feb; 14(2):216-25. PubMed ID: 22935064 [TBL] [Abstract][Full Text] [Related]
18. Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn. Pediatrics; 1998 Nov; 102(5):1211-6. PubMed ID: 9794957 [TBL] [Abstract][Full Text] [Related]